argenx SE Q1 2025 Results: Revenue Soars, Net Loss Narrows

Ticker: ARGX · Form: 6-K · Filed: Jun 11, 2025 · CIK: 1697862

Sentiment: bullish

Topics: financial-results, revenue-growth, biotech

TL;DR

argenx Q1 revenue jumps to $178.1M, loss shrinks. Strong growth!

AI Summary

On June 10, 2025, argenx SE announced the publication of its first quarter 2025 financial results. The company reported total revenue of $178.1 million for Q1 2025, a significant increase from $100.1 million in Q1 2024. Net loss for the quarter was $109.5 million, compared to a net loss of $159.1 million in the prior year period.

Why It Matters

This filing provides investors with key financial performance indicators for argenx SE, highlighting revenue growth and improved profitability, which are crucial for assessing the company's current financial health and future prospects.

Risk Assessment

Risk Level: medium — The company operates in the highly competitive and regulated biotechnology sector, facing risks related to drug development, clinical trials, and market adoption.

Key Numbers

Key Players & Entities

FAQ

What was argenx SE's total revenue for the first quarter of 2025?

argenx SE reported total revenue of $178.1 million for the first quarter of 2025.

How does the Q1 2025 revenue compare to Q1 2024?

Q1 2025 revenue of $178.1 million represents a significant increase from $100.1 million in Q1 2024.

What was the net loss for argenx SE in Q1 2025?

The net loss for argenx SE in the first quarter of 2025 was $109.5 million.

How does the Q1 2025 net loss compare to the prior year period?

The net loss of $109.5 million in Q1 2025 is an improvement compared to a net loss of $159.1 million in Q1 2024.

When did argenx SE issue the press release containing these financial results?

argenx SE issued the press release containing these financial results on June 10, 2025.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on June 11, 2025 regarding ARGENX SE (ARGX).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing